Susquehanna International Group, LLP Arcus Biosciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$13.69 - $18.01 $20,535 - $27,015	-1,500 Reduced 3.31%	43,800 $669,000
Q2 2024 Aug 15, 2024	SELL	$14.59 - $18.48 $528,158 - $668,976	-36,200 Reduced 44.42%	45,300 $689,000
Q1 2024 May 07, 2024	BUY	$14.83 - $20.18 $154,232 - $209,872	10,400 Added 14.63%	81,500 $1.54 Million
Q4 2023 Feb 14, 2024	SELL	$13.43 - $19.63 $355,895 - $520,195	-26,500 Reduced 27.15%	71,100 $1.36 Million
Q3 2023 Nov 14, 2023	SELL	$17.62 - $23.54 $525,076 - $701,492	-29,800 Reduced 23.39%	97,600 $1.75 Million
Q2 2023 Aug 11, 2023	SELL	$16.97 - $22.03 $957,107 - $1.24 Million	-56,400 Reduced 30.69%	127,400 $2.59 Million
Q1 2023 May 16, 2023	BUY	$15.96 - $23.15 $857,052 - $1.24 Million	53,700 Added 41.28%	183,800 $3.35 Million
Q4 2022 Feb 14, 2023	BUY	$19.7 - $35.71 $882,560 - $1.6 Million	44,800 Added 52.52%	130,100 $2.69 Million
Q3 2022 Nov 14, 2022	SELL	$23.23 - $30.07 $1.45 Million - $1.87 Million	-62,300 Reduced 42.21%	85,300 $2.23 Million
Q2 2022 Aug 15, 2022	BUY	$17.23 - $37.73 $792,580 - $1.74 Million	46,000 Added 45.28%	147,600 $3.74 Million
Q1 2022 May 16, 2022	BUY	$28.92 - $41.83 $1.9 Million - $2.75 Million	65,700 Added 183.01%	101,600 $3.21 Million
Q4 2021 Feb 14, 2022	SELL	$31.38 - $48.47 $668,394 - $1.03 Million	-21,300 Reduced 37.24%	35,900 $1.45 Million
Q3 2021 Nov 15, 2021	SELL	$26.93 - $37.68 $368,941 - $516,216	-13,700 Reduced 19.32%	57,200 $2 Million
Q2 2021 Aug 11, 2021	BUY	$22.75 - $35.77 $830,375 - $1.31 Million	36,500 Added 106.1%	70,900 $1.95 Million
Q1 2021 May 17, 2021	BUY	$26.16 - $41.39 $551,976 - $873,329	21,100 Added 158.65%	34,400 $966,000
Q4 2020 Feb 16, 2021	SELL	$17.0 - $32.36 $1.06 Million - $2.02 Million	-62,300 Reduced 82.41%	13,300 $345,000
Q3 2020 Nov 16, 2020	BUY	$17.14 - $25.47 $104,554 - $155,367	6,100 Added 8.78%	75,600 $1.3 Million
Q2 2020 Aug 14, 2020	BUY	$13.97 - $36.56 $970,915 - $2.54 Million	69,500 New	69,500 $1.72 Million

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

Black Rock Inc. New York, NY

9.76M
Shares

$149 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.47M
Shares

$83.5 Million
0.0% of portfolio
Woodline Partners LP San Francisco, CA

3.48M
Shares

$53.1 Million
0.48% of portfolio
State Street Corp Boston, MA

3.01M
Shares

$46 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

2.44M
Shares

$37.2 Million
0.1% of portfolio

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.1B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account